45 results on '"Corrêa-Giannella, Maria Lucia"'
Search Results
2. Serum albumin modified by carbamoylation impairs macrophage cholesterol efflux in diabetic kidney disease
3. Chronic advanced-glycation end products treatment induces TXNIP expression and epigenetic changes in glomerular podocytes in vivo and in vitro
4. A Hybrid Model to Predict Glucose Oscillation for Patients with Type 1 Diabetes and Suggest Customized Recommendations
5. Intestinal expression of toll-like receptor gene changes early after gastric bypass surgery and association with type 2 diabetes remission
6. Insulin Glargine U100 Improved Glycemic Control and Reduced Nocturnal Hypoglycemia in Patients with Type 2 Diabetes Mellitus and Chronic Kidney Disease Stages 3 and 4
7. Reduced intestinal FADS1 gene expression and plasma omega-3 fatty acids following Roux-en-Y gastric bypass
8. Case report: Insulinomatosis: description of four sporadic cases and review of the literature
9. Association between the CYBA and NOX4 genes of NADPH oxidase and its relationship with metabolic syndrome in non-alcoholic fatty liver disease in Brazilian population
10. AGE-albumin enhances ABCA1 degradation by ubiquitin-proteasome and lysosomal pathways in macrophages
11. Palmitic acid complexed with control or advanced glycated albumin primes human kidney tubular cells to inflammation
12. Changes in the HDL lipidome are associated with the progression of diabetic kidney disease
13. Hormetic modulation of hepatic insulin sensitivity by advanced glycation end products
14. Glycated albumin induces lipid infiltration in mice aorta independently of DM and RAS local modulation by inducing lipid peroxidation and inflammation
15. Beta-2-microglobulin (B2M) expression in the urinary sediment correlates with clinical markers of kidney disease in patients with type 1 diabetes
16. Glutathione peroxidase-1 gene (GPX1) variants, oxidative stress and risk of kidney complications in people with type 1 diabetes
17. Management of diabetes mellitus in individuals with chronic kidney disease: therapeutic perspectives and glycemic control
18. Allelic variations in the CYBA gene of NADPH oxidase and risk of kidney complications in patients with type 1 diabetes
19. Oleic and linoleic fatty acids downregulate Slc2a4/GLUT4 expression via NFKB and SREBP1 in skeletal muscle cells
20. Analysis of Pancreatic Adenocarcinoma Tumor Staging and Resection according to Previous Body Mass Index and Diabetes Duration
21. Modulation of hepatic microsomal triglyceride transfer protein (MTP) induced by S-nitroso- N-acetylcysteine in ob/ob mice
22. Reproducibility of a nylon fishing line as a screening test for diabetic foot ulceration risk
23. SLC2A4gene: a promising target for pharmacogenomics of insulin resistance
24. Hepatic gene expression profile associated with non-alcoholic steatohepatitis protection by S-nitroso- N-acetylcysteine in ob/ob mice
25. Advanced glycated albumin isolated from poorly controlled type 1 diabetes mellitus patients alters macrophage gene expression impairing ABCA-1-mediated reverse cholesterol transport
26. RAGE Mediates Cholesterol Efflux Impairment in Macrophages Caused by Human Advanced Glycated Albumin
27. Association of polymorphisms of glutamate-cystein ligase and microsomal triglyceride transfer protein genes in non-alcoholic fatty liver disease
28. Advanced Glycated apoA-IV Loses Its Ability to Prevent the LPS-Induced Reduction in Cholesterol Efflux-Related Gene Expression in Macrophages
29. MicroRNAs 1915–3p, 2861, and 4532 Are Associated with Long-Term Renal Function Decline in Type 1 Diabetes
30. Resveratrol improves glycemic control in insulin-treated diabetic rats: participation of the hepatic territory
31. Differential expression of genes encoding proteins of the HGF/MET system in insulinomas
32. Glycated Human Serum Albumin Isolated from Poorly Controlled Diabetic Patients Impairs Cholesterol Efflux from Macrophages: An Investigation by Mass Spectrometry
33. Association of a variant in the regulatory region of NADPH oxidase 4 gene and metabolic syndrome in patients with chronic hepatitis C
34. In Type 2 Diabetes Mellitus Glycated Albumin Alters Macrophage Gene Expression Impairing ABCA1‐Mediated Cholesterol Efflux
35. Abstract 460: Characterization of Glycated Albumin Isolated From Poorly Controlled Diabetic Patients and Its Role in Macrophage Cholesterol Efflux
36. Optimization of total RNA isolation from human urinary sediment
37. Sodium-glucose transporter 2 inhibitors in type 2 diabetes mellitus: navigating between Scylla and Charybdis
38. SLC2A4 gene: a promising target for pharmacogenomics of insulin resistance
39. Resveratrol improves glycemic control in insulin-treated diabetic rats: participation of the hepatic territory.
40. Differential expression of genes encoding proteins of the HGF/MET system in insulinomas.
41. Association of a variant in the regulatory region of NADPH oxidase 4 gene and metabolic syndrome in patients with chronic hepatitis C.
42. Letter to the Editor: MicroRNAs 1915–3p, 2861, and 4532 Are Associated with LongTerm Renal Function Decline in Type 1 Diabetes.
43. 649 Downregulation of Survivin Could Be a Potential Marker in Human Nonalcoholic Fatty Liver Disease (NAFLD) Progression?
44. Increased leukotriene B4 plasma concentrations in type 2 diabetes individuals with cardiovascular autonomic neuropathy
45. Glycated human serum albumin isolated from poorly controlled diabetic patients impairs cholesterol efflux from macrophages: an investigation by mass spectrometry.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.